Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and headache in children: a retrospective study from a tertiary level outpatient service

Ital J Pediatr. 2018 Aug 31;44(1):106. doi: 10.1186/s13052-018-0546-1.

Abstract

Background: In adult studies the MTHFR C677T polymorphism has been associated with an increased risk of migraine, but little research has been done in this area in children.

Methods: A retrospective study of children referred with headache to a tertiary level Paediatric Neurology Service between 2008 and 2012. This study included only patients who had been genotyped for the MTHFR C677T polymorphism. An evaluation of homocysteine serum levels was necessary to exclude other types of migraine.

Conclusion: Compared with the wild-type genotype, the T/T genotype was associated with an increased risk of any type of migraine, though the statistical significance was greatest in migraine with aura. The homocysteine serum levels were significantly higher in migraine with aura compared to migraine without aura. In a pediatric population MTHFR T/T homozygosity influences susceptibility to migraine.

Keywords: Children migraine; Hyperhomocysteinemia; MTHFR; MTHFR C677T; Migraine; Migraine with aura.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Age Distribution
  • Ambulatory Care / statistics & numerical data*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Genetic Predisposition to Disease / epidemiology*
  • Genotype
  • Homocysteine / blood
  • Humans
  • Incidence
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Migraine Disorders / diagnosis
  • Migraine Disorders / epidemiology
  • Migraine Disorders / genetics*
  • Polymorphism, Genetic*
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Tertiary Care Centers

Substances

  • Homocysteine
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)